NCT06358742

Brief Summary

This study is of a double-blind, randomised, parallel group study. Subjects will be enrolled onto the study according to the inclusion/exclusion criteria. After recruitment, subjects will be given a fluoride toothpaste without gum care agents to use for the 4-week run-in period prior to the commencement of the test phase of the study. Following the run-in period, baseline supragingival plaque samples will be collected 12 hours after last brushing, from the upper and lower jaws separately. Subjects will then then randomly allocated to one of two products (zinc citrate trihydrate \[ZCT\] toothpaste or control toothpaste) according to the randomization. Subjects will be instructed to use the toothpaste at home, brushing twice a day for 12-weeks. Supragingival plaque samples will be collected again from the upper and lower jaws after 2, 6 and 12 weeks. Plaque samples will then undergo metataxonomic and metatranscriptomic analyses.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2017

Completed
6.9 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
Last Updated

April 11, 2024

Status Verified

March 1, 2023

Enrollment Period

4 months

First QC Date

April 5, 2024

Last Update Submit

April 5, 2024

Conditions

Keywords

microbiomemetatranscriptomics

Outcome Measures

Primary Outcomes (1)

  • Plaque microbiome

    Speciation of plaque bacteria

    6 weeks

Study Arms (2)

ZCT toothpaste

EXPERIMENTAL

Brush with zinc citrate trihydrate toothpaste twice per day, morning and evening, for 12 weeks

Other: ZCT toothpaste

Control toothpaste

PLACEBO COMPARATOR

Brush with control toothpaste twice per day, morning and evening, for 12 weeks.

Other: Control toothpaste

Interventions

ZCT toothpaste
Control toothpaste

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy, adult, male/female volunteers
  • Aged between 18 and 65 years old
  • Willing to sign an informed consent and complete a medical history questionnaire
  • Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant
  • Must be available for the duration of the study

You may not qualify if:

  • The subject is an employee of Unilever or the site conducting the study
  • Subjects taking part in other oral care studies for the Sponsor or any other company
  • Smokers (including eCigarettes) or those who have smoked in the preceding 12 months.
  • Subjects showing unwillingness, inability or lack of motivation to carry out the study procedures
  • Subjects who are pregnant or nursing
  • Subjects who have used mouthwashes within the 4 weeks prior to the start of the study.
  • Subjects with a Modified Gingival Index score of 3 at screening
  • Diabetics
  • Subjects showing signs of early or untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, would affect either the scientific validity of the study or, if the subject was to participate in the study, would affect their wellbeing.
  • Subjects who have full or partial dentures or any oral piercings
  • Subjects who have an active oral herpetic lesion or regularly suffer with oral herpetic lesions
  • Subjects who regularly use medication or food supplements (including supplements which contain Zinc) in the 4 weeks prior to the start of the study, or during the study
  • Known allergies to the toothpaste ingredients or to any dental materials
  • Taking a course of antimicrobial medication within 4 weeks of screening or during the study
  • Long term use of anti-inflammatory and/or antihistamine drugs. Intermittent use is permitted apart from 24 hours prior to the assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Plaque

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic Diseases

Study Officials

  • Robert Maclure, BDS

    Intertek CRS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Toothpaste packaged in white tubes with a study label which only differentiates products with a alphanumeric code.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2024

First Posted

April 11, 2024

Study Start

January 10, 2017

Primary Completion

May 19, 2017

Study Completion

May 19, 2017

Last Updated

April 11, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share